USClinicalTrials.govClinical trialNot applicableActive, not recruiting
Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma
Official record
- Identifier
NCT05464823- Recruiting locations
country
United States- Interventions studied
- Molecular Functional Portrait
- Lead sponsor
- M.D. Anderson Cancer Center
- Target enrolment
- 111 participants
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Status
- Active, not recruiting
- First posted
- Jul 19, 2022
- Last updated on the registry
- Aug 14, 2026
- Age
- 18 Years
- Sex
- ALL
- Study contact
- No public contact is listed on the official record.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Patient Eligibility: Inclusion Criteria: 1. Male/female patients who are at least 18 years of age on the day of informed consent signing. 2. Patients must have a histologically documented diffuse large B-cell lymphoma requiring therapy. 3. Provision of written informed consent for the study. Exclusion Criteria: 1\. None
- Indexed under
- Lymphoma